Table 3 Values of V5, V20 and mean lung dose (MLD) in total lung and top 20%, 30% and 40% functional lung regions for all the investigated anatomic treatment plans
Patient | Anatomic | Functional lung region | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total lung | 20% | 30% | 40% | |||||||||
V5 (%) | V20 (%) | MLD (Gy) | V5 (%) | V20 (%) | MLD (Gy) | V5 (%) | V20 (%) | MLD (Gy) | V5 (%) | V20 (%) | MLD (Gy) | |
1 | 11.6 | 7.1 | 3.8 | 5.1 | 2.6 | 1.6 | 7.9 | 4.4 | 2.6 | 9.4 | 5.6 | 3.2 |
2 | 26.74 | 16.9 | 9.3 | 17.9 | 9.7 | 5.5 | 21 | 11.8 | 6.7 | 22.9 | 13.4 | 7.6 |
3 | 50.6 | 18.6 | 11.07 | 40.6 | 15.8 | 9.4 | 42.6 | 17 | 9.9 | 42.6 | 17.4 | 10 |
4 | 25.2 | 17.8 | 9.4 | 16.1 | 10.6 | 5.8 | 19.6 | 13.3 | 7.2 | 22.3 | 15.5 | 8.3 |
5 | 47.3 | 16.8 | 10.3 | 29.2 | 8.3 | 6 | 36.2 | 12 | 7.9 | 40.1 | 13.9 | 8.8 |
6 | 41.9 | 16.2 | 8.6 | 27 | 8.5 | 5.4 | 33.9 | 11.9 | 6.8 | 38.1 | 14.2 | 7.7 |
AVG ± STD | 33.9 ± 15.1 | 15.6 ± 4.2 | 8.7 ± 2.6 | 22.7 ± 12.3 | 9.3 ± 4.3 | 5.6 ± 2.5 | 26.9 ± 12.9 | 11.7 ± 4.1 | 6.9 ± 2.4 | 29.2 ± 13.1 | 13.3 ± 4.1 | 7.6 ± 2.3 |
7 | 66.4 | 30.3 | 16.7 | 67.4 | 31.2 | 17.1 | 67.1 | 30 | 16.8 | 67.1 | 30 | 16.7 |
8 | 34.4 | 18.3 | 8.7 | 38.3 | 21.8 | 9.9 | 36.7 | 20.4 | 9.3 | 36.4 | 20.2 | 9.3 |
9 | 57.7 | 25.7 | 13.2 | 45 | 19.3 | 10.2 | 51.5 | 23 | 11.9 | 55.5 | 25.1 | 12.9 |
10 | 62.1 | 27.2 | 14.4 | 64.1 | 26 | 14.1 | 62.3 | 25.3 | 13.7 | 61.1 | 25 | 13.6 |
11 | 46.7 | 29.5 | 17.8 | 31.4 | 13.3 | 9.2 | 37.4 | 18.5 | 12.1 | 40.9 | 22.1 | 14 |
AVG ± STD | 53.5 ± 12.9 | 26.2 ± 4.8 | 14.2 ± 3.6 | 49.2 ± 15.9 | 22.3 ± 6.8 | 12.1 ± 3.4 | 51.0 ± 13.9 | 23.4 ± 4.5 | 12.7 ± 2.7 | 52.2 ± 13.1 | 24.5 ± 3.7 | 13.2 ± 2.5 |